Annual Drug Patent Expirations for XERAVA
Xerava is a drug marketed by Tetraphase Pharms and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has seventy patent family members in thirty-two countries.
The generic ingredient in XERAVA is eravacycline dihydrochloride. One supplier is listed for this compound. Additional details are available on the eravacycline dihydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
